Literature DB >> 32355328

Impaired interferon signature in severe COVID-19.

Conor Gruber1.   

Abstract

Entities:  

Year:  2020        PMID： 32355328      PMCID： PMC7192056          DOI： 10.1038/s41577-020-0335-0

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   53.106


× No keyword cloud information.
  12 in total

Review 1.  Role of SARS-CoV-2 in Modifying Neurodegenerative Processes in Parkinson's Disease: A Narrative Review.

Authors:  Jeremy M Morowitz; Kaylyn B Pogson; Daniel A Roque; Frank C Church
Journal:  Brain Sci       Date:  2022-04-22

Review 2.  Targeting TANK-binding kinase 1 (TBK1) in cancer.

Authors:  Or-Yam Revach; Shuming Liu; Russell W Jenkins
Journal:  Expert Opin Ther Targets       Date:  2020-10-05       Impact factor: 6.902

Review 3.  Signaling by cGAS-STING in Neurodegeneration, Neuroinflammation, and Aging.

Authors:  Bindu D Paul; Solomon H Snyder; Vilhelm A Bohr
Journal:  Trends Neurosci       Date:  2020-11-10       Impact factor: 13.837

4.  Impact of SARS-CoV-2 infection on the recovery of peripheral blood mononuclear cells by density gradient.

Authors:  Maria D I Manunta; Giuseppe Lamorte; Francesca Ferrari; Elena Trombetta; Mario Tirone; Cristiana Bianco; Alessandra Cattaneo; Luigi Santoro; Guido Baselli; Manuela Brasca; Mahnoosh Ostadreza; Elisa Erba; Andrea Gori; Alessandra Bandera; Laura Porretti; Luca V C Valenti; Daniele Prati
Journal:  Sci Rep       Date:  2021-03-01       Impact factor: 4.379

5.  Covid-19 and breastfeeding: what's the risk?

Authors:  Ivan L Hand; Lawrence Noble
Journal:  J Perinatol       Date:  2020-07-13       Impact factor: 2.521

Review 6.  Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics.

Authors:  Negin Ebrahimi; Saeed Aslani; Farhad Babaie; Maryam Hemmatzadeh; Ramin Hosseinzadeh; Zeinab Joneidi; Zahra Mehdizadeh Tourzani; Nafiseh Pakravan; Hamed Mohammadi
Journal:  Int Immunopharmacol       Date:  2020-10-10       Impact factor: 4.932

Review 7.  Glycophosphopeptical AM3 Food Supplement: A Potential Adjuvant in the Treatment and Vaccination of SARS-CoV-2.

Authors:  Diego Fernández-Lázaro; Cesar I Fernandez-Lazaro; Juan Mielgo-Ayuso; David P Adams; Juan Luis García Hernández; Jerónimo González-Bernal; Marcela González-Gross
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

8.  Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID-19 in type 2 diabetes.

Authors:  Fawaz Alzaid; Jean-Baptiste Julla; Marc Diedisheim; Charline Potier; Louis Potier; Gilberto Velho; Bénédicte Gaborit; Philippe Manivet; Stéphane Germain; Tiphaine Vidal-Trecan; Ronan Roussel; Jean-Pierre Riveline; Elise Dalmas; Nicolas Venteclef; Jean-François Gautier
Journal:  EMBO Mol Med       Date:  2020-09-11       Impact factor: 12.137

Review 9.  The Inflammasome in Times of COVID-19.

Authors:  Juan Carlos de Rivero Vaccari; W Dalton Dietrich; Robert W Keane; Juan Pablo de Rivero Vaccari
Journal:  Front Immunol       Date:  2020-10-08       Impact factor: 7.561

10.  Effects of the lockdown on the mental health of the general population during the COVID-19 pandemic in Italy: Results from the COMET collaborative network.

Authors:  Andrea Fiorillo; Gaia Sampogna; Vincenzo Giallonardo; Valeria Del Vecchio; Mario Luciano; Umberto Albert; Claudia Carmassi; Giuseppe Carrà; Francesca Cirulli; Bernardo Dell'Osso; Maria Giulia Nanni; Maurizio Pompili; Gabriele Sani; Alfonso Tortorella; Umberto Volpe
Journal:  Eur Psychiatry       Date:  2020-09-28       Impact factor: 5.361
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.